SURUNKALI GEPATITLAR DIETOTERAPIYASINI MAHALLIY O'SIMLIK OQSILIGA BOY VA IXTISOSLASHGAN PARHEZ MAHSULOTLARI BILAN TAKOMILLASHTIRISH

Gulbahor Sharafaddinova

Authors

Gulbahor Sharafaddinova Urganch davlat tibbiyot instituti, Ichki kasalliklar, nefrologiya, gemodializ va reabilitologiya kafedrasi assistenti, Urganch, O`zbekiston Author

Keywords:

surunkali gepatit, dietoterapiya, o'simlik oqsili, mosh, no'xat, soya

Abstract

Ushbu tadqiqot surunkali gepatit (SG) bilan og'rigan 120 nafar bemorni qamrab olib, mahalliy o'simlik oqsiliga boy mahsulotlar (mosh, no'xat, soya) asosidagi ixtisoslashgan parhez rejimining jigar funksiyasi ko'rsatkichlariga ta'sirini baholaydi. 6 oylik kuzatuv davomida alanin aminotransferaza (ALT) va aspartat aminotransferaza (AST) darajalari, albumin ko'rsatkichi hamda jigar tolasi fibrozlanish indekslari tahlil qilindi. Natijalar shuni ko'rsatdiki, mahalliy o'simlik oqsilidan foydalanish ALT va AST darajalarini sezilarli darajada kamaytirdi, albumin sintezini yaxshiladi va bemorlarning hayot sifatini oshirdi. Tadqiqot mahalliy oziq-ovqat mahsulotlari asosidagi dietoterapiya protokollarini kliniq amaliyotga joriy etishning maqsadga muvofiqligini asoslaydi.

Downloads

Download data is not yet available.

References

1. World Health Organization. Global hepatitis report, 2017. Geneva: WHO; 2017. 68 p.

2. Sulaymonova D.R., Raxmatullayev A.I. O'zbekistonda surunkali gepatitlar epidemiologiyasi. O'zbek tibbiyot jurnali. 2020;3:45–51.

3. Mikolasevic I., Milic S., Orlic L. et al. Metabolic syndrome and non-alcoholic fatty liver disease. Med Sci Monit. 2016;22:4405–4411.

4. Ataxonovich, J.A., Samadova, A. and Maratovna, D.D., 2024. MODERN TREATMENT METHODS FOR HEPATORENAL SYNDROME. Web of Medicine: Journal of Medicine, Practice and Nursing, 2(12), pp.147-154.

5. Ruzmetov, N. A., A. B. Samadova, and Q. F. Abdullayev. "DIAGNOSIS OF KIDNEY DAMAGE AND CHRONIC KIDNEY DISEASE AFTER LIVER DISEASES AMONG THE POPULATION OF KHOREZM REGION." Talqin va tadqiqotlar ilmiy-uslubiy jurnali 2.56 (2024): 235-240.

6. Ataxonovich, Jabbarov Azimboy, and Shegay Olga Alekseyevna. "HEPATORENAL SYNDROME PREDICTORS OF CLINICAL, PATHOGENETIC, AND GENETIC FACTORS." Western European Journal of Medicine and Medical Science 2.12 (2024): 20-27.

7. Ataxonovich, J.A., Samadova, A. and Gulxayo, P., 2025. NEW MEDICAL TECHNOLOGIES FOR 14.EARLY DIAGNOSIS AND TREATMENT OF HEPATORENAL SYNDROME. Multidisciplinary Journal of Science and Technology, 5(3), pp.262-267.

8. “CLINICAL AND LABORATORY ASSESSMENT OF RENAL DYSFUNCTION IN LIVER CIRRHOSIS” (2025) SOUTH ARAL SEA MEDICAL JOURNAL, 1(Maxsus son), pp. 126–130. Available at: https://jurnal.urgfiltma.uz/index.php/SASRSMJ/article/view/214 (Accessed: 24 December 2025).

9. Ataxonovich, J.A., Samadova, A. and Maratovna, D.D., 2025. Advancements in the Diagnosis and Treatment of Hepatorenal Syndrome: The Role of Modern Medical Technologies. Multidisciplinary Journal of Science and Technology, 5(3), pp.392-396.

10. Samadova, A., 2025. CLINICAL AND LABORATORY ASSESSMENT OF RENAL DYSFUNCTION IN LIVER CIRRHOSIS. SOUTH ARAL SEA MEDICAL JOURNAL, 1(Maxsus son), pp.126-130.

11. Jabbarov, A.A., 11-7 (81) 2025-Jabbarov AA, Samadova A.-PROGNOSTIC ROLE OF SERUM CYSTATIN C IN THE EARLY DETECTION OF HEPATORENAL SYNDROME AMONG CIRRHOTIC INDIVIDUALS.